EPH4 Burden and Characteristics of COVID-19 in France During 2020 Based on National Hospital Database von Leboucher, C, Blein, C, Machuron, V, Le Lay, K, Benyounes, K, Millier, A, Raffi, F

Volltext

1218P FALCONS, a non-interventional retrospective study in resected NSCLC patients using the EPITHOR database, first analysis von Wislez, M., Alifano, M., Michiels, S., Lena, H., Emonnot, L., Esnault, C., Gally, S., Goncalves, L., Kuypers, C., Machuron, V., Micon, S., Saget, S., Thokagevistk, K., Boyer, L., Dahan, M., Thomas, P.A.

Volltext

EPH64 Public Health Impact of COVID-19 in French Ambulatory Patients With at Least One Risk Factor for Severe Disease von Supiot, R, Millier, A, Benyounes, K, Machuron, V, Le Lay, K, Sivignon, M, Leboucher, C, Blein, C, Raffi, F

Volltext

PCN277 Analysis of Treatment Sequences in HER2-Positive EARLY Breast Cancer Patients: A Retrospective Study from the French National Hospital Database Using a Machine Learning Algo... von Laurent, M., Prodel, M., Vainchtock, A., Gilberg, M., Ghorbal, R., Machuron, V., Tehard, B., Dupin, J.

Volltext

PCN525 FIRST VALUE-BASED PRICE AGREEMENT IN FRANCE BASED ON PRM REAL-WORLD DATA von Cozzone, D., Samelson, L., Machuron, V., Da Costa, J., Tehard, B., Pinguet, J.M.

Volltext

Patients' description and resource use in COVID-19 hospitalized patients based on a French claims real-world database von Leboucher, C., Blein, C., Le Maout, A., Machuron, V., Benyounes, K., Le Lay, K., Millier, A., Raffi, Pr

Volltext

CO10.7 - Plateforme de données de vie réelle ODH: élaboration d'un observatoire du médicament en oncologie von Benhajkassen, N., Bosquet, L., Deniau, M., Bachot, C., Guesmia, T., Robert, V., Machuron, V., Martin, A.

Volltext

PRM72 - The Personalised Reimbursement Models (Prm): Real World Data Collection to Provide Innovative Pricing Solutions in France von Doly, A, Coudert, B, Cottu, P, Manson, J, Barletta, H, Perol, D, Aujoulat, O, Azria, D, Pivot, X, Montastier, R, Grandfils, N, Pinguet, J, Machuron, V, Samelson, L, Tehard, B

Volltext

The Personalised Reimbursement Models (Prm): Real World Data Collection to Provide Innovative Pricing Solutions in France von Doly, A, Coudert, B, Cottu, P, Manson, J, Barletta, H, Perol, D, Aujoulat, O, Azria, D, Pivot, X, Montastier, R, Grandfils, N, Pinguet, J, Machuron, V, Samelson, L, Tehard, B

Volltext

Patients' description and resource use in COVID-19 hospitalized patients based on a French claims real-world database von Leboucher, C., Blein, C., Le Maout, A., Machuron, V., Benyounes, K., Le Lay, K., Millier, A., Raffi, Pr

Volltext

Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study von Vantyghem, Marie-Christine, Chetboun, Mikael, Gmyr, Valéry, Jannin, Arnaud, Espiard, Stéphanie, Le Mapihan, Kristell, Raverdy, Violeta, Delalleau, Nathalie, Machuron, François, Hubert, Thomas, Frimat, Marie, Van Belle, Eric, Hazzan, Marc, Pigny, Pascal, Noel, Christian, Caiazzo, Robert, Kerr-Conte, Julie, Pattou, François

Volltext

Intrauterine balloon tamponade in the management of severe postpartum haemorrhage after vaginal delivery: Is the failure early predictable? von Leleu, A., Ghesquiere, L., Machuron, F., Caudrelier, C., Devouge, P., Subtil, D., Houflin-Debarge, V., Garabedian, C.

Volltext

1795P - Does bevacizumab increase joint pain? Preliminary results of the BEVARTHRALGIA study von Enora, V., Turpin, A., Lebellec, L., Mouamnia, A., Machuron, F., Vieillard, M.H.

Volltext

1795PDoes bevacizumab increase joint pain? Preliminary results of the BEVARTHRALGIA study von Enora, V, Turpin, A, Lebellec, L, Mouamnia, A, Machuron, F, Vieillard, M H

Volltext

Does bevacizumab increase joint pain? Preliminary results of the BEVARTHRALGIA study von Enora, V., Turpin, A., Lebellec, L., Mouamnia, A., Machuron, F., Vieillard, M.H.

Volltext

PO-41: Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial? von Petit, B., Soudet, S., Poenou, G., Zarrat, E., Machuron, T., Accassat, S., Plaisance, L., Helfer, H., Mismetti, V., Le Hello, C., Sevestre, M.-A., Mahé, I., Bertoletti, L.

Volltext

Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial? von Petit, B., Soudet, S., Poenou, G., Zarrat, E., Machuron, T., Accassat, S., Plaisance, L., Helfer, H., Mismetti, V., Le Hello, C., Pietri-Sevestre, Marie-Antoinette, Mahe, I., Bertoletti, L.

Volltext

TEMPORARY REMOVAL: PO-41: Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial? von Petit, B, Soudet, S, Poenou, G, Zarrat, E, Machuron, T, Accassat, S, Plaisance, L, Helfer, H, Mismetti, V, Le Hello, C, Sevestre, M-A, Mahé, I, Bertoletti, L

Volltext

Maladie thromboembolique veineuse associée au cancer : combien de patients atteints de cancer du poumon vus en pratique clinique seraient éligibles à un essai contrôlé randomisé su... von Petit, B., Mismetti, V., Soudet, S., Poenou, G., Zarrat, E., Machuron, T., Accassat, S., Plaisance, L., Helfer, H., Le Hello, C., Sevestre, M.A., Mahé, I., Bertoletti, L.

Volltext